MolNFT v1 · #33481 · protein
4-arylazo-3,5-diamino-1H-pyrazole cdk inhibitors: sar study, crystal structure in complex with CDK2, selectivity, and cellular effects
2CLX: “4-arylazo-3,5-diamino-1H-pyrazole cdk inhibitors: sar study, crystal structure in complex with CDK2…”. X-ray diffraction. MolNFT v1 #33481 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 2CLX
- Type
- protein
- Length
- 293 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- UniProt
- P24941
Structure
x-ray diffraction · 1 distinct chain.
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | — | protein | 293 | — | P24941 |
Compared structures
- 2CLX · 4-Arylazo-3,5-diamino-1H-pyrazole CDK Inhibitors: SAR Study, Crystal Structure in Complex… · the same entry in another collection · chain A against A, TM-score 1.00
- P24941 · AlphaFold monomer V2.0 prediction for cyclin-dependent kinase 2 (P24941) · a predicted model of the same protein · chain A against A, TM-score 0.94
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P24941
- Elsewhere: RCSB PDB 2CLX · PDBe 2CLX · UniProt P24941
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.